DK3344282T3 - Glycosidhydrolaser og anvendelse heraf til forebyggelse og/eller behandling af en patogen infektion hos et dyr - Google Patents

Glycosidhydrolaser og anvendelse heraf til forebyggelse og/eller behandling af en patogen infektion hos et dyr Download PDF

Info

Publication number
DK3344282T3
DK3344282T3 DK16766724.5T DK16766724T DK3344282T3 DK 3344282 T3 DK3344282 T3 DK 3344282T3 DK 16766724 T DK16766724 T DK 16766724T DK 3344282 T3 DK3344282 T3 DK 3344282T3
Authority
DK
Denmark
Prior art keywords
treat
animal
prevent
pathogenic infection
glycoside hydrolases
Prior art date
Application number
DK16766724.5T
Other languages
English (en)
Inventor
Charlotte Horsmans Poulsen
Svend Haaning
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Application granted granted Critical
Publication of DK3344282T3 publication Critical patent/DK3344282T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01051—Alpha-L-fucosidase (3.2.1.51)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK16766724.5T 2015-09-02 2016-08-30 Glycosidhydrolaser og anvendelse heraf til forebyggelse og/eller behandling af en patogen infektion hos et dyr DK3344282T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562213564P 2015-09-02 2015-09-02
PCT/US2016/049439 WO2017040499A1 (en) 2015-09-02 2016-08-30 Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal

Publications (1)

Publication Number Publication Date
DK3344282T3 true DK3344282T3 (da) 2020-12-14

Family

ID=56940378

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16766724.5T DK3344282T3 (da) 2015-09-02 2016-08-30 Glycosidhydrolaser og anvendelse heraf til forebyggelse og/eller behandling af en patogen infektion hos et dyr

Country Status (12)

Country Link
US (2) US10933121B2 (da)
EP (2) EP3711773A1 (da)
JP (1) JP6914250B2 (da)
KR (1) KR20180043365A (da)
CN (1) CN108348585B (da)
CA (1) CA2997213C (da)
DK (1) DK3344282T3 (da)
ES (1) ES2835067T3 (da)
MX (1) MX2018002617A (da)
PH (1) PH12018500447A1 (da)
RU (1) RU2720243C2 (da)
WO (1) WO2017040499A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102225240B1 (ko) * 2019-07-03 2021-03-10 경북대학교 산학협력단 다제내성 병원성 세균을 효과적으로 사멸시키는 재조합 항균 단백질 Ablysin의 용도
EP4294426A1 (en) * 2021-02-16 2023-12-27 DSM IP Assets B.V. Methods for reducing pathogenic e coli by selective feed additive intervention comprising enzymes such as muramidase
WO2023028454A1 (en) * 2021-08-23 2023-03-02 Dupont Nutrition Biosciences Aps Feed additive compositions and methods for using the same

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607398B2 (en) 1985-08-29 1991-03-07 Genencor Inc. Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US5231020A (en) 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
ES2322032T3 (es) 1990-12-10 2009-06-16 Genencor Int Sacrificacion mejorada de celulosa por clonacion y amplificacion del gen de beta-glucosidasa de trichoderma reesei.
DK13491D0 (da) 1991-01-25 1991-01-25 Novo Nordisk As Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform
US5433946A (en) * 1991-10-11 1995-07-18 Health Research Inc. Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases
WO1994025061A1 (en) * 1993-04-23 1994-11-10 Glyko, Inc. Methods and compositions for treating diseases with carbohydrate modifying enzymes
US5861271A (en) 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
WO1996000787A1 (en) 1994-06-30 1996-01-11 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
WO1997016076A1 (en) 1995-11-02 1997-05-09 Novo Nordisk A/S Feed enzyme preparations
US6255115B1 (en) 1997-04-07 2001-07-03 Unilever Patent Holdings Bv Agrobacterium mediated transformation of moulds, in particular those belonging to the genus Aspergillus
AU737862B2 (en) * 1997-05-20 2001-08-30 Biotechnology Research And Development Corporation Methods and compositions to identify swine genetically resistant to F18 E. Coli associated diseases
US6268328B1 (en) 1998-12-18 2001-07-31 Genencor International, Inc. Variant EGIII-like cellulase compositions
EP1228158B1 (de) 1999-08-24 2008-07-30 Henkel AG & Co. KGaA Verklebung durch Klebstoffe enthaltend nanoskalige Teilchen
RU2173556C1 (ru) * 2000-07-11 2001-09-20 Жирков Игорь Николаевич Способ лечения массовых диспепсий новорожденного молодняка крупного рогатого скота
US7232670B2 (en) 2001-09-28 2007-06-19 St. Jude Children's Research Hospital Targeting proteins to cells expressing mannose receptors via expression in insect cells
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
DK1862626T3 (da) 2003-05-29 2011-12-12 Genencor Int Nye Trichoderma-gener
EP2497478A3 (en) * 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccaride compositions and use thereof in the treatment of infection
EP2497370A3 (en) 2005-10-12 2013-11-20 Danisco US Inc. Stable, durable granules with active agents
JP2012519500A (ja) * 2009-03-09 2012-08-30 クテロス， インコーポレイテッド クロストリジウム（Ｃｌｏｓｔｒｉｄｉｕｍ）種からの発酵最終産物の生産
CN102703506A (zh) * 2012-02-10 2012-10-03 安徽农业大学 α1,2-岩藻糖转移酶基因沉默的体细胞克隆猪及其生产方法与应用
WO2015017256A1 (en) 2013-07-29 2015-02-05 Danisco Us Inc. Variant enzymes

Also Published As

Publication number Publication date
EP3344282B8 (en) 2020-12-23
CN108348585B (zh) 2023-12-15
EP3344282A1 (en) 2018-07-11
CA2997213C (en) 2021-01-19
US20210236606A1 (en) 2021-08-05
WO2017040499A1 (en) 2017-03-09
JP6914250B2 (ja) 2021-08-04
PH12018500447A1 (en) 2018-09-10
RU2018111399A (ru) 2019-10-02
KR20180043365A (ko) 2018-04-27
US10933121B2 (en) 2021-03-02
CN108348585A (zh) 2018-07-31
ES2835067T3 (es) 2021-06-21
EP3344282B1 (en) 2020-09-23
MX2018002617A (es) 2018-07-06
CA2997213A1 (en) 2017-03-09
EP3711773A1 (en) 2020-09-23
JP2018527357A (ja) 2018-09-20
US20190022193A1 (en) 2019-01-24
RU2720243C2 (ru) 2020-04-28
RU2018111399A3 (da) 2019-10-28

Similar Documents

Publication Publication Date Title
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
KR20180084895A (ko) 효소 내재화 조성물 및 방법
DK3389658T3 (da) Glycosidasehæmmere og anvendelser deraf
DK3689076T3 (da) PDCP-UL-opdeling og forbehandling
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
DK3302471T3 (da) Tetrasubstituerede alkenforbindelser og deres anvendelse
DK3212777T3 (da) Endoglucanasevarianter hos svamper samt fremstilling og anvendelse deraf
BR112016016289A2 (pt) heteroaris e usos dos mesmos
DK3328211T3 (da) Tørre citrusfibre og anvendelser deraf
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3346056T3 (da) Rengøringssystem og fremgangsmåde
DK3390325T3 (da) Gødning omfattende bakterier og protozoer
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3692009T3 (da) Biocementationsfremgangsmåde og system
DK3316951T3 (da) Eyewear and flexible elements
MA49905A (fr) Polyesteramines et polyesterquats
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3417058T3 (da) Sortase-modificerede molekyler og anvendelser deraf
DK3420039T3 (da) Printningsformuleringer og fremgangsmåder
BR112017015618A2 (pt) inibidores de mir-92 e usos destes.
DK3490988T3 (da) Ny forbindelse og fremgangsmåde
DK3177728T4 (da) Forbedrede fermenteringsfremgangsmåder ved anvendelse af xylanase og pectinase
DK3344282T3 (da) Glycosidhydrolaser og anvendelse heraf til forebyggelse og/eller behandling af en patogen infektion hos et dyr
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf